The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate
Open accessAbstract
Alkali therapy of metabolic acidosis in patients with chronic kidney disease (CKD) with plasma total CO2 (TCO2) below 22 mmol/l per KDOQI guidelines appears to preserve estimated glomerular filtration rate (eGFR). Since angiotensin II mediates GFR decline in partial nephrectomy models of CKD and even mild metabolic acidosis increases kidney angiotensin II in animals, alkali treatment of CKD-related metabolic acidosis in patients with plasma TCO2 over 22 mmol/l might preserve GFR through reduced kidney angiotensin II. To test this, we randomized 108 patients with stage 3 CKD and plasma TCO2 22-24 mmol/l to Usual Care or interventions designed to reduce dietary acid by 50% using sodium bicarbonate or base-producing fruits and vegetables. All were treated to achieve a systolic blood pressure below 130 mm Hg with regimens including angiotensin converting enzyme inhibition and followed for 3 years. Plasma TCO2 decreased in Usual Care but increased with bicarbonate or fruits and vegetables. By contrast, urine excretion of angiotensinogen, an index of kidney angiotensin II, increased in Usual Care but decreased with bicarbonate or fruits and vegetables. Creatinine-calculated and cystatin C-calculated eGFR decreased in all groups, but loss was less at 3 years with bicarbonate or fruits and vegetables than Usual Care. Thus, dietary alkali treatment of metabolic acidosis in CKD that is less severe than that for which KDOQI recommends therapy reduces kidney angiotensin II activity and preserves eGFR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both treatments ameliorated metabolic acidosis and indices of kidney injury and did so without producing hyperkalemia.”
From Plant Proteins: Assessing Their Nutritional Quality and Effects on Health and Physical Function (2020) · cites this paper as [102]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Wright, J. T. (2002) · JAMA · doi:10.1001/jama.288.19.2421 · Cited by 2,039
Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
Dharnidharka, V. R., Kwon, C. Y., & Stevens, G. R. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34487 · Cited by 1,669
Pathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,258
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,066
Kopple, J. D. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20748 · Cited by 1,029
Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status
de Brito-Ashurst, I., Varagunam, M., Raftery, M., & Yaqoob, M. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111205 · Cited by 854
Potential Renal Acid Load of Foods and its Influence on Urine pH
Remer, T., & Manz, F. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00219-7 · Cited by 742
Cited by
Sorted by citations
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
KDOQI clinical practice guideline for nutrition in CKD: 2020 update
Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.006 · Cited by 1,960
Lichtenstein, A. H., Appel, L. J., Vadiveloo, M., Hu, F. B., Kris-Etherton, P. M., Rebholz, C. M., Sacks, F. M., Thorndike, A. N., Van Horn, L., Wylie-Rosett, J., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001031 · Cited by 1,065
Wallace, T. C., Bailey, R. L., Blumberg, J. B., Burton-Freeman, B., Chen, C.-Y. O., Crowe-White, K. M., Drewnowski, A., Hooshmand, S., Johnson, E., Lewis, R., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632258 · Cited by 638
Plant Proteins: Assessing Their Nutritional Quality and Effects on Health and Physical Function
Hertzler, S. R., Lieblein-Boff, J. C., Weiler, M., & Allgeier, C. (2020) · Nutrients · doi:10.3390/nu12123704 · Cited by 594
Metadata
- Authors
- Goraya, N., Simoni, J., Jo, C.-H., & Wesson, D. E.
- Affiliations
- Baylor Scott & White Medical Center - Temple (US)
- Corresponding author
- Wesson, Donald E.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 86
- Issue
- 5
- Pages
- 1031-1038
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2014046186
- Cited by
- 399
- References
- 42
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 27 · 2023: 47 · 2022: 42 · 2021: 48 · 2020: 40 · 2019: 41 · 2018: 29 · 2017: 41 · 2016: 21 · 2015: 20 · 2014: 4
- FWCI
- 22.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Renal function and acid-base balance
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Urology › Kidney Stones and Urolithiasis Treatments
- Keywords
- metabolic acidosis, chronic kidney disease stage 3, alkali therapy, sodium bicarbonate, fruits and vegetables, angiotensin II, estimated glomerular filtration rate, ACE inhibitors, cystatin C
- MeSH terms
- Acid-Base Equilibrium, Acidosis, Administration, Oral, Angiotensinogen, Bicarbonates, Diet, Female, Fruit, Glomerular Filtration Rate, Humans, Kidney, Male, Middle Aged, Time Factors, Vegetables, Biomarkers, Treatment Outcome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review